Fish Oil Supplements Lower Serum Lipids and Glucose in Correlation with a Reduction in Plasma Fibroblast Growth Factor 21 and Prostaglandin E2 in Nonalcoholic Fatty Liver Disease Associated with Hyperlipidemia: A Randomized Clinical Trial.

Fish Oil Supplements Lower Serum Lipids and Glucose in Correlation with a Reduction in Plasma Fibroblast Growth Factor 21 and Prostaglandin E2 in Nonalcoholic Fatty Liver Disease Associated with Hyperlipidemia: A Randomized Clinical Trial.

Item
http://www.wikidata.org/entity/Q35726506
Role of n-3 Polyunsaturated Fatty Acids in Ameliorating the Obesity-Induced Metabolic Syndrome in Animal Models and HumansCurcumin and long-chain Omega-3 polyunsaturated fatty acids for Prevention of type 2 Diabetes (COP-D): study protocol for a randomised controlled trial.Elevated Fibroblast growth factor 21 (FGF21) in obese, insulin resistant states is normalised by the synthetic retinoid Fenretinide in mice.N-3 polyunsaturated fatty acids increase hepatic fibroblast growth factor 21 sensitivity via a PPAR-γ-β-klotho pathway.Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease.The effect of omega-3 unsaturated fatty acids on non-alcoholic fatty liver disease: A systematic review and meta-analysis of RCTs.Fatty Acids Consumption: The Role Metabolic Aspects Involved in Obesity and Its Associated Disorders.Comparison of the effect of omega-3 supplements and fresh fish on lipid profile: a randomized, open-labeled trial.Fibroblast growth factor 21 decreases after liver fat reduction via growth hormone augmentation.Evaluation of a High Concentrate Omega-3 for Correcting the Omega-3 Fatty Acid Nutritional Deficiency in Non-Alcoholic Fatty Liver Disease (CONDIN)Omega-3 polyunsaturated fatty acid supplementation and non-alcoholic fatty liver disease: A meta-analysis of randomized controlled trialsPotential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD
P2860

Fish Oil Supplements Lower Serum Lipids and Glucose in Correlation with a Reduction in Plasma Fibroblast Growth Factor 21 and Prostaglandin E2 in Nonalcoholic Fatty Liver Disease Associated with Hyperlipidemia: A Randomized Clinical Trial.

Item
http://www.wikidata.org/entity/Q35726506
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Fish Oil Supplements Lower Ser ...... : A Randomized Clinical Trial.
@ast
Fish Oil Supplements Lower Ser ...... : A Randomized Clinical Trial.
@en
type
label
Fish Oil Supplements Lower Ser ...... : A Randomized Clinical Trial.
@ast
Fish Oil Supplements Lower Ser ...... : A Randomized Clinical Trial.
@en
prefLabel
Fish Oil Supplements Lower Ser ...... : A Randomized Clinical Trial.
@ast
Fish Oil Supplements Lower Ser ...... : A Randomized Clinical Trial.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Fish Oil Supplements Lower Ser ...... : A Randomized Clinical Trial.
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0133496
P407
P433
P478
P577
P5875
P698
P921
P932